Shared on 01 May 25
Fair value Decreased 2.65%High Valuations And Execution Risks Will Depress Returns
Shared on 23 Apr 25
High Valuations And Execution Risks Will Depress Returns
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
High Valuations And Execution Risks Will Depress Returns
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
High Valuations And Execution Risks Will Depress Returns
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
High Valuations And Execution Risks Will Depress Returns
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Fair value Decreased 26%High Valuations And Execution Risks Will Depress Returns
AnalystConsensusTarget has decreased revenue growth from 3.4% to -0.8%.
Shared on 19 Mar 25
Fair value Increased 16%High Valuations And Execution Risks Will Depress Returns
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Increased 19%High Valuations And Execution Risks Will Depress Returns
AnalystConsensusTarget has increased revenue growth from -0.8% to 3.4%, increased future PE multiple from 35.6x to 46.4x and increased shares outstanding growth rate from -0.1% to 0.1%.